Founder of Blueprint. I help companies stop sending emails nobody wants to read.
The problem with outbound isn't the message. It's the list. When you know WHO to target and WHY they need you right now, the message writes itself.
I built this system using government databases, public records, and 25 million job posts to find pain signals most companies miss. Predictable Revenue is dead. Data-driven intelligence is what works now.
Your GTM team is buying lists from ZoomInfo, adding "personalization" like mentioning a LinkedIn post, then blasting generic messages about features. Here's what it actually looks like:
The Typical Change Healthcare (now Optum) SDR Email:
Why this fails: The prospect is an expert. They've seen this template 1,000 times. There's zero indication you understand their specific situation. Delete.
Blueprint flips the approach. Instead of interrupting prospects with pitches, you deliver insights so valuable they'd pay consulting fees to receive them.
Stop: "I see you're hiring compliance people" (job postings - everyone sees this)
Start: "Your Medicare Advantage plan dropped from 3.5 to 3.0 stars in the October 2024 CMS ratings release" (government database with exact rating)
PQS (Pain-Qualified Segment): Reflect their exact situation with such specificity they think "how did you know?" Use government data with dates, record numbers, facility addresses.
PVP (Permissionless Value Proposition): Deliver immediate value they can use today - analysis already done, deadlines already pulled, patterns already identified - whether they buy or not.
These messages demonstrate precise understanding backed by verifiable data. Every claim traces to specific data sources.
Alert Part D sponsors to specific ZIP codes where their beneficiaries average 15+ miles to contracted pharmacies—CMS 2026 standards require <5 miles rural/<2 miles urban. Show exact member counts at risk, which counties trigger violations, and which pharmacies to contract. Prevents $500K+ CMS audit penalties and mandatory corrective action plans.
You're surfacing a regulatory violation before CMS finds it. The specificity—exact ZIP codes, member counts, distance calculations—proves this isn't a generic warning. You're preventing a penalty, not selling a feature.
This play combines CMS pharmacy access rules with pharmacy location data and the plan's current network. Requires analysis of member residential addresses cross-referenced with contracted pharmacy locations.
This synthesis is unique to your business - you're showing them a compliance gap they can't see from their own data alone.Analyze Q3 appeals data to show that 2,341 of 4,187 appeals stem from just 3 denial code patterns. Fixing these 3 adjudication rules would eliminate 56% of appeals volume and drop MLR by 2.8 points. Deliver the denial code analysis and system fix recommendations.
You're not highlighting the problem—they already know about the appeals. You're showing them the root cause with surgical precision. Three specific denial codes = fixable problem. This creates immediate urgency and a clear path to resolution.
This play requires access to appeals data with ability to analyze denial code patterns and calculate MLR impact. Assumes your company processes claims and appeals for this MCO.
This is proprietary analysis only you can provide - competitors cannot replicate this insight without processing their claims data.Alert providers that 12 orthopedic surgeons have denial rates above 34%, costing them $2.1M in lost revenue. Map the specific documentation gaps and payer-specific requirements causing the denials. Deliver surgeon-level breakdown with fix recommendations.
You're identifying a revenue leak with dollar precision. Naming the exact provider count and percentage creates credibility. Promising "fix recommendations" shows you've done the analysis, not just identified the problem.
This play requires claims data with provider-level denial rates and ability to identify documentation patterns. Assumes your company processes claims for this provider organization.
This is proprietary data only you have - competitors cannot send this insight without processing their claims.Alert neurosurgery practices that their denial rate is 41%, versus 18% for other specialties. That's $3.7M in annual revenue they're writing off that should be collected. Deliver the denial code breakdown and recovery roadmap.
Comparing their neurosurgery denial rate to their own other specialties removes the "our patients are sicker" excuse. The dollar amount creates urgency. Promising a "recovery roadmap" shows you've already done the work.
This play requires revenue cycle data showing denial rates by specialty with ability to calculate recovery opportunities. Assumes your company processes claims for this provider organization.
This is proprietary data only you have - competitors cannot deliver this analysis without processing their claims.Alert that cardiology service line denial rate jumped from 12% to 17.6% in November 2024. Identify 3 specific CPT codes and 2 documentation patterns driving the spike. Deliver the denial breakdown by provider and procedure code.
The sudden spike creates urgency—this is a new problem that just emerged. Naming specific CPT codes and documentation patterns proves you've done the analysis. The recent timeframe means they can still fix it quickly.
This play requires aggregated claims data across multiple payers showing denial patterns by service line, CPT code, and provider. Assumes your company processes claims for this organization.
This is proprietary data only you have - competitors cannot identify these patterns without processing their claims volume.Alert oncology practices that 87 claims over $25K each are stuck in payer appeals for 90+ days. Identify which 34 of those have the highest overturn probability based on payer-specific patterns. Deliver prioritized appeals list with winning documentation strategies.
You're identifying trapped revenue with specific dollar thresholds. The 90+ day aging creates urgency. Prioritizing the 34 most winnable appeals shows sophistication—you're not just identifying problems, you're triaging their workload.
This play requires claims aging data with appeals success rate patterns by payer and claim type. Assumes your company processes claims and appeals for this provider organization.
This is proprietary intelligence only you can deliver - competitors cannot prioritize appeals without your historical success rate data.Alert physical therapy practices that UnitedHealthcare denies 67% of their PT claims versus 14% to other payers. Identify the 3 specific documentation requirements UHC enforces differently than others. Deliver payer-specific documentation checklist.
Isolating one payer's denial rate versus others proves this isn't a quality issue—it's a payer-specific documentation gap. The stark contrast (67% vs 14%) creates urgency. Promising an actionable checklist shows immediate value.
This play requires claims data showing denial rates by payer with ability to identify payer-specific documentation requirements. Assumes your company processes claims for this provider organization.
This is proprietary intelligence only you can deliver - competitors cannot identify payer-specific patterns without processing multi-payer claims volume.Analyze 2025 Star Rating components to show that 14 specific measures scored below 3 stars and cost them the overall 3.5 rating. Identify which 6 measures have the fastest improvement ROI based on member population and intervention costs. Deliver prioritized measure improvement roadmap.
You're translating their public Star Rating into actionable intelligence. Prioritizing by ROI shows you understand their resource constraints. This is consultation-grade analysis they'd normally pay for.
This play combines public CMS Star Ratings data with analysis of measure improvement costs and member population characteristics. Requires healthcare operations expertise to calculate intervention ROI.
This synthesis is unique to your business - you're translating public data into strategic prioritization they cannot do alone.Identify that the ACO's quality decline is concentrated in 8 specific measures - all have proven interventions that show results in 6-9 months. Map which measures give the biggest quality score lift for 2025 reporting. Deliver measure-by-measure intervention playbook.
You're converting their declining trajectory into a fixable problem. The 6-9 month timeline shows it's not too late. ROI prioritization demonstrates you understand their resource constraints.
This play combines public ACO quality performance data with intervention effectiveness research and timeline analysis. Requires healthcare quality improvement expertise.
This synthesis is unique to your business - you're translating public data into strategic action plans they cannot build alone.Analyze the hospital's last 3 CMS surveys to show that infection control citations appeared in all 3, escalating from standard to immediate jeopardy. Identify the 4 specific protocols that keep failing and map them to staff training gaps. Deliver citation pattern analysis and training recommendations.
The escalation pattern proves this isn't bad luck—it's a systemic failure. Identifying the recurring protocols shows you've done forensic analysis. Mapping to training gaps provides a clear remediation path.
This play combines public CMS survey data with analysis of citation patterns and root cause identification. Requires healthcare compliance expertise to identify training gaps.
This synthesis is unique to your business - you're translating public inspection records into actionable remediation plans.Target MA plans whose October 2024 Star Rating fell to 3.0, triggering loss of Quality Bonus Payment eligibility. Calculate the exact revenue impact: $135 per member per month they're not getting = $120M annual revenue at risk with 74,000 members. Route to person mapping the measure improvement roadmap.
The QBP loss is a massive financial impact that creates board-level urgency. You're quantifying the exact dollar amount using their public member count. This isn't fear-mongering—it's math.
Target CAHs with 5 immediate jeopardy citations from November 2024 survey results. This triggers a 23-day Plan of Correction deadline and puts decertification in play if they miss it. Route to person coordinating the correction plan submission.
Immediate jeopardy is the most severe citation level—it means patients are at risk right now. The 23-day deadline creates extreme urgency. Decertification is an existential threat for a CAH.
Target ACOs whose quality score fell from 74.1 to 68.3 in 2024 CMS MSSP results. Below 70 means they're ineligible for shared savings even if they hit cost targets - $4.2M they earned but won't receive. Route to person leading the quality measure recovery plan.
The shared savings loss is painful—they did the work to reduce costs but won't see the financial reward. The exact dollar amount creates urgency. This is a governance-level failure that demands immediate action.
Target MA plans whose rating dropped from 3.5 to 3.0 stars in October 2024 CMS release. This triggers a 2.42% payment cut starting January 2025 - approximately $18M based on their 74,000 member count. Route to person leading the Star Ratings recovery effort.
You're citing the exact rating drop with specific numbers. The real financial impact calculated for their plan size creates urgency. The immediate timeline (January 2025 start) makes this a current crisis, not a future concern.
Target ACOs with 3 consecutive years of declining quality scores - 78.2 (2022), 74.1 (2023), 68.3 (2024). Another 6-point drop in 2025 puts them below the 60-point MSSP participation threshold for 2026. Route to person analyzing the measure-level performance gaps.
The multi-year trend shows a clear trajectory toward exclusion. Naming the specific threshold (60 points) creates clarity about what's at stake. This is an existential threat that demands immediate intervention.
Target MCOs whose Medicaid MLR reached 91.2% in Q3 2024 - above the 85% regulatory threshold. This triggers premium rebates to the state and potential contract non-renewal discussions. Route to person driving the MLR reduction initiative.
The specific MLR number from public filing creates credibility. Regulatory threshold breach is serious—it triggers financial penalties and puts the contract at risk. This is a board-level crisis.
Target Part D plans with network gaps in Harris, Dallas, and Tarrant counties based on CMS updated pharmacy access standards from October 2024. The 2026 audit cycle starts March 2025, and network adequacy violations trigger enrollment sanctions. Route to person managing the pharmacy network expansion.
Naming specific counties where they're non-compliant proves you've done the analysis. The recent regulatory update creates urgency. Enrollment sanctions are an existential threat—no new members means revenue decline.
Target MCOs with 4,187 member appeals filed in Q3 (up 34% from Q2) - that's 2.8x the state average. This signals operational breakdowns in claims adjudication. Route to person analyzing the appeals root cause patterns.
The exact appeal count from public data creates credibility. Comparison to state average adds context—this isn't just high volume, it's an outlier. The operational implication is clear: something is broken.
Target CAHs whose overall rating fell to 2 stars in the October 2024 refresh. CAHs below 3 stars enter Special Focus Facility candidacy for enhanced CMS oversight and more frequent surveys. Route to person mapping the improvement strategy.
SFF program is a serious escalation—it means CMS is watching them closely. Enhanced oversight means more frequent surveys and higher risk of citations. This creates urgency to fix issues before the next survey.
Target Part D plans with 8-mile gaps in rural areas based on CMS updated rules from October 2024. Rural areas now require pharmacies within 8 miles. Network has gaps in 14 rural counties across service area. Route to person handling pharmacy contracting for rural access.
The specific distance requirement creates clarity. County-level specificity proves you've done the analysis. Recent rule change creates urgency—this is a new compliance risk.
Old way: Spray generic messages at job titles. Hope someone replies.
New way: Use public data to find companies in specific painful situations. Then mirror that situation back to them with evidence.
Why this works: When you lead with "Your Medicare Advantage plan dropped from 3.5 to 3.0 stars in October 2024" instead of "I see you're hiring for quality roles," you're not another sales email. You're the person who did the homework.
The messages above aren't templates. They're examples of what happens when you combine real data sources with specific situations. Your team can replicate this using the data recipes in each play.
Every play traces back to verifiable public data. Here are the sources used in this playbook:
| Source | Key Fields | Used For |
|---|---|---|
| CMS Medicare Advantage/Part D Contract and Enrollment Data | contract_id, plan_name, organization_name, enrollment_count, cms_compare_5_star_rating | MA/Part D Plans - Star Ratings, enrollment, QBP eligibility |
| CMS Medicaid Managed Care Dashboard and MDCT Data | mcpar_data, medical_loss_ratio, appeals_and_grievances, plan_name, state, compliance_status | Medicaid MCOs - MLR compliance, appeals volume, program integrity |
| CMS ACO Performance Data and Public Use Files | aco_id, aco_name, quality_scores, financial_results, track, beneficiary_demographics | ACOs - quality performance, shared savings eligibility, MSSP exclusion risk |
| CMS Provider Data Catalog - Hospital Quality and Readmissions | facility_id, facility_name, cms_compare_5_star_rating, quality_measures, readmission_rates | Hospitals - quality benchmarking, readmission reduction, CMS ratings |
| CMS Medicare Part D Plan Sponsor Reporting Data | plan_sponsor_name, plan_id, network_adequacy_metrics, grievance_data, cost_data | Part D Plans - pharmacy network adequacy, PBM transparency compliance |
| State Health Department Hospital Inspection Records | facility_name, inspection_date, deficiency_type, severity_level, statement_of_deficiency | Hospitals - inspection deficiencies, immediate jeopardy citations, compliance risk |
| CMS Medicaid Program Integrity and Fraud Detection Data | state, provider_name, fraud_type, violation_date, penalty_amount, exclusion_status | State Medicaid Agencies/MCOs - fraud detection, provider exclusion, cost containment |
| Internal Claims Processing Data | denial_rates, CPT codes, provider_specialty, geographic_region, payer_patterns | Providers/Payers - denial hotspots, revenue recovery, operational efficiency |
| Internal Revenue Cycle Metrics | claims_processing_time, appeal_success_rates, days_to_payment, rework_costs | Providers - RCM performance benchmarking, working capital optimization |
| Internal Member/Pharmacy Utilization Data | prescription_fill_locations, pharmacy_access_by_zip, contracted_pharmacy_locations | Part D Plans - network adequacy compliance, pharmacy contracting priorities |